earnings
confidence high
sentiment neutral
materiality 0.50
Outset Medical Q3 revenue $30.4M (+9% YoY); net loss $46.2M; reiterates FY23 guidance ~$130M
Outset Medical, Inc.
2023-Q3 EPS reported
-$2.72
revenue$99,869,000
- Revenue $30.4M, +9% YoY; product rev $23.5M (+8.2%), service rev $6.8M (+13.4%).
- GAAP gross margin 23.6% (vs 15.6% YoY); non-GAAP 25.6% (vs 16.4% YoY). Service margin dropped to 6.8% from 37%.
- Net loss $46.2M ($0.93/share); non-GAAP net loss $35.3M ($0.71/share).
- Cash $197M as of Sept 30; operating expenses $52.6M.
- Reiterated 2023 revenue guidance ~$130M, gross margin low-20% for year, mid-20% in Q4.